Capital Research Global Investors’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-557,461	Closed	-$67.6M	–	427
2023 Q3	$67.6M	Buy	557,461 +78	+0%	+$8.82K	0.02%	304
2023 Q2	$63.8M	Buy	557,383 +291,442	+110%	+$37.6M	0.02%	313
2023 Q1	$36.7M	Buy	+265,941	New	+$34.5M	0.01%	343
2021 Q4	–	Sell	-2,542,191	Closed	-$235M	–	464
2021 Q3	$235M	Sell	2,542,191 -2,208,578	-46%	-$170M	0.05%	234
2021 Q2	$369M	Sell	4,750,769 -3,276,134	-41%	-$248M	0.09%	196
2021 Q1	$598M	Buy	8,026,903 +290,155	+4%	+$26.8M	0.15%	139
2020 Q4	$1.32B	Buy	7,736,748 +1,025,424	+15%	+$152M	0.34%	74
2020 Q3	$942M	Buy	6,711,324 +2,006,643	+43%	+$305M	0.28%	83
2020 Q2	$754M	Buy	4,704,681 +829,723	+21%	+$113M	0.24%	95
2020 Q1	$379M	Buy	3,874,958 +1,465,905	+61%	+$168M	0.15%	128
2019 Q4	$311M	Buy	+2,409,053	New	+$243M	0.09%	177